Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET)

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorBeijing Chao Yang Hospital

About this trial

Dexmedetomidine can attenuate the activity of the sympathetic nervous system under stress response and improve ischemia-reperfusion injury. The investigators hypothesized that the prolonged sedation of dexmedetomidine after successful reperfusion of endovascular thrombectomy may improve the clinical outcome of acute ischemic stroke patients.

Eligibility criteria

Qualifiers

2≤NIHSS≤25

mRS score before stroke was less than 3

Acute ischemic stroke (including anterior circulation)

mTICI rate 2b or 3

Disqualifiers

Intracerebral hemorrhage occurred in the responsible vessel area in the past 6 weeks

Patients who had received stent treatment at the responsible vessel in the past

Neurological function was restored at or before angiography

Patients who are allergic to heparin, aspirin, clopidogrel, rapamycin, lactic acid polymer, poly (n-butyl methacrylate), stainless steel, anesthetics and contrast agents or have contraindications

Trial design

Treatments tested in this trial

  • Dexmedetomidine prolonged sedation
  • 0.9% saline

Treatment groups

368 Participants
are divided into 2 treatment groups

Sponsors and collaborators